Omacetaxine Mepesuccinate for Chronic Myeloid Leukemia-Reference-Cited by-同舟云学术

Omacetaxine Mepesuccinate for Chronic Myeloid Leukemia

Published:2016-04-21 Issue:5 Volume:9 Page:419-424
ISSN:1747-4086
Container-title:Expert Review of Hematology
language:en
Short-container-title:Expert Review of Hematology

Author:

Rosshandler Yasmin¹,Shen Ann Q.¹,Cortes Jorge²,Khoury Hanna Jean¹

Affiliation:

1. Department of Hematology and Medical Oncology, the Winship Cancer Institute of Emory University, Emory University School of Medicine, Atlanta, GA, USA

2. Department of Leukemia, the University of Texas M.D. Anderson Cancer Center, Houston, TX, USA

Publisher

Informa UK Limited

Subject

Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1586/17474086.2016.1151351

Reference57 articles.

1. The Biology of Chronic Myeloid Leukemia

2. Chronic Myeloid Leukemia

3. Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experience

4. Gleevec (Imatinib Mesylate). Administration USFaD. Silver Springs, MD:U.S. Department of Health and Human Services, 2003. [cited 2014 Oct 20]. Available from: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm110502.htm

5. FDA approves dasatinib (Sprycel) for use in the treatment of adults with chronic phase, accelerated phase, or myeloid or lymphoid blast phase chronic myeloid leukemia. Administration USFaD. Silver Spring, MD:U.S. Department of Health and Human Services, 2006. [cited 2014 Oct 6]. Available at: http://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDER/ucm095630.htm

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Homoharringtonine: updated insights into its efficacy in hematological malignancies, diverse cancers and other biomedical applications;European Journal of Medical Research;2024-05-04

2. MILIP Binding to tRNAs Promotes Protein Synthesis to Drive Triple-Negative Breast Cancer;Cancer Research;2024-04-09

3. Targeting Translation and the Cell Cycle Inversely Affects CTC Metabolism but Not Metastasis;Cancers;2023-11-02

4. Developing therapeutic approaches for chronic myeloid leukemia: a review;Molecular and Cellular Biochemistry;2022-10-10

5. Structural insight into the binding pattern and interaction mechanism of chemotherapeutic agents with Sorcin by docking and molecular dynamic simulation;Colloids and Surfaces B: Biointerfaces;2021-12